More one-year-olds will qualify for an RSV antibody shot this winter under guidance the American Academy of Pediatrics released Wednesday, which widened the list of medical conditions that make a toddler eligible for protection in a second RSV season.
The academy's updated policy statement in Pediatrics keeps the core recommendation intact: essentially every infant under 8 months born during or entering a first RSV season should be protected, unless the baby already has documented protection from a parent's vaccination during pregnancy. What changed sits one age bracket up. The statement says a review of evidence supports expanding the high-risk criteria for children 8 through 19 months entering their second season.
